Moderna, Inc.

NASDAQ Global Select
Back to all articles
Neutral 0

Moderna (NASDAQ:MRNA) CFO James Mock Sells 34,836 Shares

AI-generated analysis

📉 CFO James Mock sold 34,836 shares for approximately $4.69 million under a pre-arranged Rule 10b5-1 trading plan on September 10th.

💰 The sale reduced the CFO's direct ownership stake by 36.98%, leaving him with 59,375 shares valued at roughly $7.99 million.

📈 Moderna reported quarterly revenue of $145 million, surpassing analyst estimates of $102.93 million and growing 2.1% year-over-year.

💸 The company posted a loss of $1.97 per share for the quarter, resulting in a negative net margin of 141.43%.

🏦 Institutional ownership stands at 75.33%, with BlackRock and California State Teachers Retirement System adding significant positions recently.

📊 Goldman Sachs raised its price target to $120, while Weiss Ratings maintains a 'sell' rating on the stock.

Bullish Signals
  • Moderna reported quarterly revenue of $145 million, which beat analyst estimates of $102.93 million and grew 2.1% year-over-year.
  • Goldman Sachs raised its price target on the stock from $67 to $120 in a recent research note.
Risk Factors
  • The company reported a loss of $1.97 per share for the quarter, resulting in a negative net margin of 141.43%.
  • Weiss Ratings restated its rating on shares to 'sell (d-)' in a report dated September 9th.
Full Analysis
Moderna CFO James Mock executed a pre-arranged Rule 10b5-1 trading plan on September 10th, selling 34,836 shares at an average price of $134.49. This transaction reduced his direct ownership stake by approximately 37%, leaving him with 59,375 shares valued at roughly $7.99 million. The sale was disclosed via a document filed with the Securities & Exchange Commission. Financially, Moderna reported quarterly revenue of $145 million, which beat analyst estimates of $102.93 million and represented a 2.1% year-over-year increase. Despite the revenue beat, the company posted a loss of $1.97 per share compared to an estimated loss of $2.03, resulting in a negative net margin of 141.43%. The stock currently trades with a market capitalization of $58.56 billion. Institutional ownership remains significant at 75.33%, with major investors like BlackRock and California State Teachers Retirement System increasing their stakes in the second quarter. Analyst sentiment is mixed, with Goldman Sachs raising its price target to $120 while Weiss Ratings maintains a sell rating, resulting in a consensus 'Hold' rating and a consensus price target of $76.72.